FDA Panel Votes Down Oral Testosterone Replacement Products FDA Panel Votes Down Oral Testosterone Replacement Products

FDA advisers were primarily concerned about risk of cardiovascular side effects, which they felt could become a problem, particularly with off-label use of such products, which they believe is widespreadMedscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news